Community-based Microalbuminuria Screening in Patients With Hypertension
NCT03596840 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2018-07-26
Summary
This study evaluates the effectiveness of different anti-hypertensive drugs on patients with hypertension and microalbuminuria.
Conditions
- Hypertension
- Microalbuminuria
Sponsors & Collaborators
-
Shanghai Zhongshan Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-01
- Primary Completion
- 2020-07-31
- Completion
- 2020-12-31
More Related Trials
-
Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
NCT05688579 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Preventing Microalbuminuria in Type 2 Diabetes
NCT00503152 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.
NCT00200694 ·Status: TERMINATED ·Phase: PHASE4
-
Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
NCT00338091 ·Status: TERMINATED ·Phase: NA
-
Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination
NCT04143412 ·Status: UNKNOWN ·Phase: PHASE2
-
Risk Factors Contributing to the Development of Microalbuminuria
NCT00572403 ·Status: COMPLETED
-
The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism
NCT06236698 ·Status: COMPLETED
-
Management of Albuminuria in Hypertensive Diabetics
NCT01907958 ·Status: UNKNOWN
-
The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography
NCT03329443 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus
NCT02046395 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension
NCT00921570 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
NCT00890279 ·Status: UNKNOWN ·Phase: PHASE2
-
High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy
NCT00212901 ·Status: COMPLETED ·Phase: NA
-
Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) Patients
NCT01284114 ·Status: COMPLETED ·Phase: PHASE4
-
Hyperuricemia and Left Ventricular Diastolic Function
NCT03495999 ·Status: TERMINATED
-
Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
NCT06203236 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension
NCT06780865 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension
NCT04952051 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy of rhBNP in Patients With Diuretic Resistance After Cardiac Surgery
NCT07086287 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease
NCT00638222 ·Status: TERMINATED ·Phase: NA
-
The Influence of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Patients Undergoing Non-emergent Coronary Angiography
NCT01071642 ·Status: COMPLETED ·Phase: NA
-
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
NCT07020104 ·Status: RECRUITING ·Phase: NA
-
Screening for Primary Aldosteronism in Hypertension With 24-hour URinary aLdosterone
NCT06047912 ·Status: UNKNOWN
-
Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
NCT00528385 ·Status: COMPLETED ·Phase: NA
-
Human Urine Sample Collection for Alport Nephropathy Biomarker Studies
NCT01602835 ·Status: TERMINATED